低血压治疗策略能否改善出血性休克合并重型创伤性脑损伤实验模型的脑灌注与氧合?
该研究在32只20-30 kg猪中建立侧方液压打击致脑损伤联合压力控制放血至MAP 40 mmHg的出血性休克模型,随机分为对照、盐水(60 ml/kg 0.9% NaCl)、特利加压素(2 mg)及盐水加特利加压素(20 ml/kg 0.9% NaCl+2 mg)四组。结果显示特利加压素组及盐水加特利加压素组MAP升高并持续至实验结束(p<0.05),但所有组开始抗休克治疗后颅内压均明显升高,脑灌注压与脑氧饱和度在血流动力学恢复后均无改善,接受盐水复苏组治疗后血红蛋白浓度最低。作者结论认为,在出血性休克合并重型TBI实验模型中,用盐水联合或不联合特利加压素治疗低血压不能恢复脑灌注或脑氧合,MAP升高因TBI所致脑自动调节功能障碍而升高颅内压。
要点
- 猪出血性休克合并重型TBI模型中,特利加压素(2 mg)及盐水(20 ml/kg 0.9% NaCl)加特利加压素(2 mg)组MAP升高并持续至实验结束(p<0.05)。
- 所有组开始抗休克治疗后颅内压均明显升高。
- 任何组在血流动力学恢复后脑灌注压和脑氧饱和度均无改善。
- 接受盐水复苏的组治疗后血红蛋白浓度最低。
- 作者结论:盐水联合或不联合特利加压素治疗低血压不能恢复该模型脑灌注或脑氧合。
适用人群与场景
- 32只体重20-30 kg的猪,建立侧方液压打击致脑损伤联合压力控制放血至MAP 40 mmHg的出血性休克模型。
- 出血性休克持续30分钟后启动复苏。
诊断标准与关键阈值
- 出血性休克通过压力控制放血诱导,目标平均动脉压(MAP)为40 mmHg。
- 脑损伤通过侧方液压打击诱导。
处置流程与药物剂量
- 对照组:不予治疗。
- 盐水组:60 ml/kg 0.9% NaCl。
- 特利加压素组:2 mg特利加压素。
- 盐水加特利加压素组:20 ml/kg 0.9% NaCl+2 mg特利加压素。
- 休克持续30分钟后按组别启动复苏。
研究设计与关键结果
- 研究类型:实验动物研究;32只猪随机分为四组:对照、盐水、特利加压素、盐水加特利加压素。
- 特利加压素组和盐水加特利加压素组MAP升高并持续至实验结束(p<0.05)。
- 所有组开始抗休克治疗后颅内压明显升高。
- 血流动力学恢复后,任何组脑灌注压和脑氧饱和度均无改善。
- 接受盐水复苏的组治疗后血红蛋白浓度最低。
- 统计学方法:重复测量方差分析,显著性水平p<0.05。
证据类型、等级与局限
- 证据类型:动物实验(猪模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在出血性休克合并重型TBI模型中,用盐水联合或不联合特利加压素治疗低血压不能恢复脑灌注或脑氧合。
- 作者认为,MAP升高因TBI所致脑自动调节功能障碍而升高颅内压。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Restoration of brain tissue perfusion is a determining factor in the neurological evolution of patients with traumatic brain injury (TBI) and hemorrhagic shock (HS). In a porcine model of HS without neurological damage, it was observed that the use of fluids or vasoactive drugs was effective in restoring brain perfusion; however, only terlipressin promoted restoration of cerebral oxygenation and lower expression of edema and apoptosis markers. It is unclear whether the use of vasopressor drugs is effective and beneficial during situations of TBI. The objective of this study is to compare the effects of resuscitation with saline solution and terlipressin on cerebral perfusion and oxygenation in a model of TBI and HS.
METHODS: Thirty-two pigs weighing 20-30 kg were randomly allocated into four groups: control (no treatment), saline (60 ml/kg of 0.9% NaCl), terlipressin (2 mg of terlipressin), and saline plus terlipressin (20 ml/kg of 0.9% NaCl + 2 mg of terlipressin). Brain injury was induced by lateral fluid percussion, and HS was induced through pressure-controlled bleeding, aiming at a mean arterial pressure (MAP) of 40 mmHg. After 30 min of circulatory shock, resuscitation strategies were initiated according to the group. The systemic and cerebral hemodynamic and oxygenation parameters, lactate levels, and hemoglobin levels were evaluated. The data were subjected to analysis of variance for repeated measures. The significance level established for statistical analysis was p < 0.05.
RESULTS: The terlipressin and saline plus terlipressin groups showed an increase in MAP that lasted until the end of the experiment (p < 0.05). There was a notable increase in intracranial pressure in all groups after starting treatment for shock. Cerebral perfusion pressure and cerebral oximetry showed no improvement after hemodynamic recovery in any group. The groups that received saline at resuscitation had the lowest hemoglobin concentrations after treatment.
CONCLUSIONS: The treatment of hypotension in HS with saline and/or terlipressin cannot restore cerebral perfusion or oxygenation in experimental models of HS and severe TBI. Elevated MAP raises intracranial pressure owing to brain autoregulation dysfunction caused by TBI.
参考来源
- Balzi APCC, Otsuki DA, Andrade L, et al. Can a Therapeutic Strategy for Hypotension Improve Cerebral Perfusion and Oxygenation in an Experimental Model of Hemorrhagic Shock and Severe Traumatic Brain Injury? Neurocrit Care. 2023. PMID: 37535176. doi:10.1007/s12028-023-01802-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。